ORAMED PHARMACEUTICALS INC. Quarterly Return On Equity in % from Q4 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Oramed Pharmaceuticals Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q2 2024.
  • Oramed Pharmaceuticals Inc. Return On Equity for the quarter ending June 30, 2024 was 12.8 %.
  • Oramed Pharmaceuticals Inc. annual Return On Equity for 2023 was 3.61 %.
  • Oramed Pharmaceuticals Inc. annual Return On Equity for 2022 was -23.6 %, a 18.4% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 12.8 +25.9 Apr 1, 2024 Jun 30, 2024
Q1 2024 6.67 +25.9 Jan 1, 2024 Mar 31, 2024
Q4 2023 3.61 +27.2 Oct 1, 2023 Dec 31, 2023
Q3 2023 -10.7 +14.8 +58.1% Jul 1, 2023 Sep 30, 2023
Q2 2023 -13.2 +12.8 +49.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -19.3 +4.75 +19.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -23.6 +1.46 +5.83% Oct 1, 2022 Dec 31, 2022
Q3 2022 -25.6 +3.38 +11.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 -25.9 +9.74 +27.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 -24 +19.6 +45% Jan 1, 2022 Mar 31, 2022
Q4 2021 -25.1 +28.3 +53.1% Sep 1, 2021 Dec 31, 2021
Q3 2021 -28.9 Jul 1, 2021 Aug 31, 2021
Q2 2021 -35.7 Apr 1, 2021 Jun 30, 2021
Q1 2021 -43.6 Jan 1, 2021 Mar 31, 2021
Q4 2020 -53.4 Sep 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.